ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SAVA Cassava Sciences Inc

21.40
0.66 (3.18%)
Last Updated: 11:48:54
Delayed by 15 minutes

Period:

Draw Mode:

Volume 258,311
Bid Price 21.32
Ask Price 21.41
News -
Day High 21.64

Low
12.3202

52 Week Range

High
32.10

Day Low 20.4263
Company Name Stock Ticker Symbol Market Type
Cassava Sciences Inc SAVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.66 3.18% 21.40 11:48:54
Open Price Low Price High Price Close Price Prev Close
20.4263 20.4263 21.64 20.74
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,076 258,311 $ 21.05 $ 5,437,326 - 12.3202 - 32.10
Last Trade Time Type Quantity Stock Price Currency
11:48:54 100 $ 21.40 USD

Cassava Sciences (SAVA) Options Flow Summary

Overall Flow

Bullish

Net Premium

41k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Cassava Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
12.1M 43.23M - 0 -97.22M -2.25 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cassava Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SAVA Message Board. Create One! See More Posts on SAVA Message Board See More Message Board Posts

Historical SAVA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week21.2321.9419.4720.42806,6830.170.80%
1 Month20.2626.675719.43522.121,005,3401.145.63%
3 Months24.2726.675718.1821.94739,767-2.87-11.83%
6 Months14.7832.1014.611523.241,018,9026.6244.79%
1 Year22.7032.1012.320221.72981,005-1.30-5.73%
3 Years40.54146.1612.320249.632,377,071-19.14-47.21%
5 Years1.10146.161.0034.202,782,86320.301,845.45%

Cassava Sciences Description

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

Your Recent History

Delayed Upgrade Clock